Diabetes Vanishes Overnight After Surgery

Two hands exchanging a red heart symbol in a surgical setting

A tap dancer chained to insulin shots and dialysis machines broke free through a single surgery, reclaiming her rhythm and life without diabetes.

Story Snapshot

Nakia Odem underwent simultaneous kidney-pancreas transplant at Mayo Clinic, ending Type 1 diabetes and kidney failure.
Procedure restored natural insulin production, eliminated dialysis, insulin, and diet restrictions.
Odem resumed tap dancing, symbolizing full quality-of-life recovery.
Mayo Clinic pioneers SPK transplants, including robotic techniques for better outcomes.
SPK offers hope to T1DM patients, with comparable results even for select T2DM cases.

Nakia Odem’s Desperate Path to Transplant

Nakia Odem battled Type 1 diabetes for years. High blood sugar destroyed her kidneys, leading to end-stage renal disease. Daily insulin injections and dialysis sessions drained her energy and passion for tap dancing. Mayo Clinic evaluated her as ideal for simultaneous pancreas-kidney (SPK) transplant. Surgeons scheduled the dual-organ procedure in early 2026. Donor organs arrived, setting the stage for transformation. Odem entered surgery knowing success could end her medical chains forever.

The operation succeeded. Doctors transplanted a healthy kidney to replace her failed one and a pancreas to produce insulin naturally. Odem woke without dialysis ports or insulin pumps. Blood sugar stabilized immediately. Weeks later, she walked freely, no longer tethered to machines. Tap shoes called her back to the studio. This medical feat cured her diabetes at its root, not just managed symptoms.

SPK Transplant Mechanics and Eligibility

SPK transplants target Type 1 diabetes patients with kidney failure. The pancreas graft secretes insulin, curing hyperglycemia that wrecked the kidneys. Kidney graft halts dialysis. Mayo Clinic performs these at specialized centers for patients on or nearing dialysis. Eligibility demands stable health to withstand surgery and immunosuppression drugs. Some Type 2 diabetes patients qualify despite insulin resistance concerns. Procedure lasts hours, with organs connected to blood vessels and digestive systems.

Post-surgery, patients follow strict anti-rejection regimens. Graft survival rates exceed kidney-only transplants. Odem’s case mirrors precedents like Brian’s 37-year diabetes saga ended by SPK at Columbia Surgery. He gained energy for exercise, much like her dancing. Studies confirm T2DM recipients achieve outcomes matching Type 1, challenging old eligibility limits.

Mayo Clinic’s Innovations Drive SPK Advances

Mayo Clinic leads SPK evolution. Surgeons like Dr. Katariya perform the procedure, declaring it attacks both kidney disease and diabetes causes. Their first robotic SPK minimized invasiveness, speeding recovery. Odem’s transplant aligned with this expertise. Broadcast scripts publicized her story in April 2026, highlighting insulin freedom. Robotic tools enhance precision, reducing complications in complex anatomies.

Kidney-pancreas transplant gives tap dancer new life without diabetes – YouTube – https://t.co/8kwjrBcpV5 #GoogleAlerts

— James Myers (@JamesMy56782210) May 1, 2026

Experts praise SPK for quality-of-life gains. RWJBarnabas Health notes elimination of insulin and dialysis needs. A 2024 review affirms superior kidney survival over solo transplants, even as new diabetes drugs emerge. Patient selection remains key; surgeons weigh risks like obesity in Type 2 cases.

Life-Changing Impacts and Future Hope

Odem dances without limits, her story inspiring T1DM sufferers. Families escape caregiving burdens. Short-term, patients ditch dialysis fatigue; long-term, fewer complications extend life. Economic sense emerges: upfront surgery costs beat endless treatments. Socially, SPK awareness grows as a true cure. Transplant demand rises, pushing donor networks. Uncertainties linger on exact graft longevity, but Odem’s vigor proves the promise.